The Cardiac and Hemodynamic Effects of Ketone Bodies Are Abnormal in Patients With Type 1 Diabetes: A Randomized

Kristoffer Berg-Hansen1,2, Maj Bangshaab2,3, Nigopan Gopalasingam1,2

  • 1Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark.

Diabetes
|June 17, 2025
PubMed

Insights

Type 1 diabetes impairs the heart's ability to use ketones for energy. This study found a significantly blunted cardiac response to ketone infusion in individuals with type 1 diabetes.

Area of Science:

  • Cardiology
  • Metabolic Disorders
  • Endocrinology

Background:

  • Diabetic hearts exhibit reduced ketone utilization due to impaired ketolytic enzyme activity.
  • Ketone bodies are an important energy substrate for the heart.

Purpose of the Study:

  • To investigate the cardiac response to 3-hydroxybutyrate infusion in type 1 diabetes.
  • To determine if impaired cardiac ketone metabolism contributes to diabetic cardiomyopathy.

Main Methods:

  • Randomized controlled crossover trial.
  • Infusion of 3-hydroxybutyrate (a ketone body).
  • Assessment of cardiac output, systolic function, and left ventricular work efficiency.

Main Results:

  • Cardiac output response to 3-hydroxybutyrate infusion was blunted by 80% in type 1 diabetes.
  • No improvement in systolic function was observed.
  • Left ventricular work efficiency was reduced in type 1 diabetes.

Conclusions:

  • Cardiac ketone metabolism is impaired in type 1 diabetes.
  • Impaired ketone utilization may contribute to the development of diabetic cardiomyopathy.
Abstract

Related Concept Videos

Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.8K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
412
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
715
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.3K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
271